FDA Plan Rejects Experimental Weight Loss Pill

Published July 20, 2010

FDA plan rejects experimental weight loss pill
A panel of federal health experts dealt a surprising setback Thursday to a highly anticipated anti-obesity pill from Vivus Inc., saying the drug’s side effects outweigh its ability to help patients lose weight.
Read more on New York Daily News